Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NIVF
NIVF logo

NIVF Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.335
Open
1.250
VWAP
1.24
Vol
154.00K
Mkt Cap
687.94K
Low
1.160
Amount
190.19K
EV/EBITDA(TTM)
--
Total Shares
568.54K
EV
3.64M
EV/OCF(TTM)
--
P/S(TTM)
0.00
NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.
Show More

Events Timeline

(ET)
2026-03-13
20:00:00
NewGenIvf Group Ltd Trading Halted, News Pending
select
2026-03-02 (ET)
2026-03-02
17:40:00
NewGenIvf Group Files to Sell 100M Class A Ordinary Shares
select
2026-03-02
08:40:00
NewGenIVF Signs MOU with Women in Web3
select
2026-02-24 (ET)
2026-02-24
08:50:00
NewGenIVF Completes Financial Transformation, Achieves $28 Million in Net Assets
select
2026-02-04 (ET)
2026-02-04
08:40:00
NewGenIVF Group Launches Inaugural Tokenized Bond Issuance
select
2026-01-27 (ET)
2026-01-27
08:40:00
NewGenIVF Group Initiates Share Repurchase Program
select
2026-01-23 (ET)
2026-01-23
20:00:00
NewGenIvf Group Ltd Trading Halted, News Pending
select
2026-01-21 (ET)
2026-01-21
08:50:00
NewGenIVF Appoints Joshua Chu as Senior Counsel to Launch $30M Tokenized Bond
select
2025-12-12 (ET)
2025-12-12
08:40:00
NewGenIVF Converts Ras Al Khaimah Project Structure, Expected Profit Increases to $123 Million
select
2025-12-02 (ET)
2025-12-02
08:11:00
NewGen Reports $3.3M Revenue for 9M, $17.5M Net Income
select

News

seekingalpha
9.5
05-04seekingalpha
NewGenIvf Reports $9.9 Million Net Profit for FY 2025
  • Net Profit Surge: For the fiscal year ending December 31, 2025, NewGenIvf reported a net profit of $9.9 million, indicating a significant increase compared to 2024, reflecting the company's strong market performance and enhanced profitability.
  • Substantial Asset Growth: As of December 31, 2025, total assets reached $32.7 million, a remarkable rise from $3.6 million in 2024, showcasing the company's success in business expansion and capital management.
  • Increased Asset Value per Share: The asset value per share stood at $135.9 in 2025, demonstrating effective strategies in asset management and shareholder value creation, which bolsters investor confidence.
  • Significant Acquisition Value: In July 2025, the company completed the acquisition of advanced cytometry intellectual property, independently valued at $17.9 million by a big-four accounting firm, resulting in a bargain purchase gain of $19.2 million, further solidifying the company's market position.
Newsfilter
9.5
05-04Newsfilter
NewGen Reports Strong Financial Performance
  • Significant Asset Growth: As of December 31, 2025, NewGen's total assets reached $32.7 million, a substantial increase from $3.6 million in 2024, demonstrating a marked improvement in financial stability that enhances investor confidence.
  • Strong Net Profit Performance: In 2025, NewGen reported a net profit attributable to shareholders of $9.9 million, primarily driven by a bargain purchase gain from the acquisition of Nodexus and Microsort, indicating successful strategic acquisitions that boosted profitability.
  • Share Repurchase Program: The company authorized a $2 million share repurchase program in November 2025, reflecting management's confidence in the company's intrinsic value and aiming to enhance shareholder returns by reducing the number of outstanding shares.
  • Advancement of Diversification Strategy: NewGen continues to push forward its diversification strategy in digital asset innovation and health supplements, indicating the company's commitment to seizing emerging opportunities in rapidly evolving markets for long-term growth and sustainability.
Newsfilter
7.5
03-02Newsfilter
NewGenIVF Partners with WiW3 to Enhance Women's Health Awareness
  • MOU Signing: NewGenIVF has signed a Memorandum of Understanding with Women in Web3 Hong Kong to collaborate on a public awareness and education campaign focused on women's health literacy, aiming to improve family planning and legacy design.
  • Diverse Activities: The campaign will feature talks, panel discussions, and community events that emphasize women's health, financial inclusion, and responsible use of emerging technologies, aiming to empower women through knowledge and open dialogue.
  • Integrated Technical Support: NewGen will leverage expertise from its health and longevity products division to provide comprehensive, technology-enabled educational resources that help women make informed choices in their health journeys.
  • Aligned Strategic Goals: This partnership aligns with NewGen's broader mission to advance women's health through its diversified subsidiaries, ensuring women are not just users but shapers of emerging technologies, enhancing their agency in life design.
Newsfilter
8.5
02-24Newsfilter
NewGenIVF Group's Remarkable Financial Transformation
  • Financial Improvement: As of September 30, 2025, NewGenIVF Group successfully transformed a historical deficit into $28 million in net assets, demonstrating the effectiveness of its capital management strategy and laying a solid foundation for future growth.
  • Diversification Strategy: In 2025, the company acquired advanced cytometry intellectual property valued at $17.9 million, forming the cornerstone of a new technology-licensing business expected to drive high-margin revenue streams and enhance market competitiveness.
  • Digital Asset Innovation: The NewGenDigital division is pioneering Real World Asset tokenization and plans to launch its first proprietary digital token in 2026, which will open new capital sources to support business development.
  • Share Repurchase Program: In November 2025, the company authorized a $2 million share repurchase program, reflecting management's confidence in the company's intrinsic value and aiming to enhance shareholder value, marking a transition into a harvesting phase.
Newsfilter
8.5
02-04Newsfilter
NewGen Successfully Launches Inaugural Tokenized Bond Campaign
  • Tokenized Bond Issuance: NewGen has successfully launched its inaugural tokenized bond Commitment Campaign on Evident Capital's platform in Hong Kong, marking the company's leadership in digital asset innovation and expected to unlock new funding sources for its UAE real estate projects through non-dilutive debt structures.
  • Rapid Execution Capability: The time taken from announcement to live investor engagement was under two weeks, showcasing NewGen's exceptional execution in complex multi-jurisdictional projects, positioning the company to capture market attention at the upcoming Consensus Hong Kong 2026 event.
  • Market Demand Assessment: The Commitment Campaign allows professional investors to submit non-binding indications of interest during a defined window, enabling NewGen to gauge real-time demand and optimize the final bond structure, ensuring effective and attractive financing.
  • Strategic Significance: This initiative not only demonstrates NewGen's innovative capabilities in the UAE real estate market but also provides a repeatable template for future tokenized financings, further solidifying Hong Kong's role as a hub connecting real-world assets with next-generation capital markets.
Globenewswire
8.5
01-21Globenewswire
NewGenIVF Appoints Legal Expert to Drive $30 Million Tokenized Bond Issuance
  • Strategic Leadership Appointment: NewGenIVF Group has appointed Web3 legal expert Joshua Chu as Senior Counsel to lead the company's inaugural $30 million tokenized bond issuance, expected to be completed in Q1 2026, thereby establishing a foundation for future tokenized financing.
  • Market Demand Response: In response to investor interest in tokenized bonds, the company has begun preparations for bond issuances linked to its UAE real estate project, aiming to provide compliant digital asset investment opportunities that enhance capital efficiency and diversify funding sources.
  • Balance Sheet Transformation: Through a non-dilutive, debt-style tokenized bond structure, NewGenIVF anticipates increasing total assets by up to $28 million in Q1 2026, driving accelerated growth and optimizing its financial structure.
  • Partnership Strengthening: Collaboration with Evident Capital provides NewGenIVF with a comprehensive tokenization and distribution platform, ensuring that the bond issuance meets institutional standards and further solidifying the company's leadership position in the digital asset space.

Valuation Metrics

The current forward P/E ratio for NewGenIvf Group Ltd (NIVF.O) is 0.36, compared to its 5-year average forward P/E of 0.07. For a more detailed relative valuation and DCF analysis to assess NewGenIvf Group Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.07
Current PE
0.36
Overvalued PE
0.31
Undervalued PE
-0.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.25
Current EV/EBITDA
-0.01
Overvalued EV/EBITDA
0.62
Undervalued EV/EBITDA
-1.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.01
Current PS
0.00
Overvalued PS
0.02
Undervalued PS
-0.01

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

market cap less than 50 millions
Intellectia · 891 candidates
Market Cap: <= 50.00M
Ticker
Name
Market Cap$
top bottom
ADTX logo
ADTX
Aditxt Inc
176.46K
FCHL logo
FCHL
Fitness Champs Holdings Ltd
210.88K
LGHL logo
LGHL
Lion Group Holding Ltd
401.09K
ONCO logo
ONCO
Onconetix Inc
440.01K
LRHC logo
LRHC
La Rosa Holdings
560.54K
NIVF logo
NIVF
NewGenIvf Group Ltd
972.21K
Low float stock screener
Intellectia · 1484 candidates
List Exchange: XNYS, XNAS, XASEFloating Shares: <= 20,000,000
Ticker
Name
Market Cap$
top bottom
LGHL logo
LGHL
Lion Group Holding Ltd
638.91K
LRHC logo
LRHC
La Rosa Holdings
711.55K
RAYA logo
RAYA
Erayak Power Solution Group Inc
831.04K
NIVF logo
NIVF
NewGenIvf Group Ltd
864.77K
QH logo
QH
Quhuo Ltd
948.08K
BDRX logo
BDRX
Biodexa Pharmaceuticals PLC
1.01M
i need quick scalp trades under a dollar
Intellectia · 2 candidates
Price: $0.10 - $1.00Price Change Pct: $3.00 - $25.00Relative Vol: >= 2Three Min Rate Of Change: >= 0.5%Monthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
IOBT logo
IOBT
IO Biotech Inc
22.60M
NIVF logo
NIVF
NewGenIvf Group Ltd
889.24K
Good cheap stock to buy
Intellectia · 746 candidates
Market Cap: <= 2.00BPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 15
Ticker
Name
Market Cap$
top bottom
NIVF logo
NIVF
NewGenIvf Group Ltd
553.20K
LGHL logo
LGHL
Lion Group Holding Ltd
755.53K
ICON logo
ICON
Icon Energy Corp
1.57M
TRNR logo
TRNR
Interactive Strength Inc
1.70M
BOXL logo
BOXL
Boxlight Corp
1.73M
DRCT logo
DRCT
Direct Digital Holdings Inc
1.74M
stocks under $1 to daytrade today
Intellectia · 15 candidates
Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TRX logo
TRX
TRX Gold Corp
271.29M
BRCC logo
BRCC
BRC Inc
247.13M
RXT logo
RXT
Rackspace Technology Inc
204.93M
HUMA logo
HUMA
Humacyte Inc
189.14M
ATCH logo
ATCH
Atlasclear Holdings Inc
36.30M
COSM logo
COSM
Cosmos Health Inc
19.42M
stocks under five dollars with low RSI
Intellectia · 11 candidates
Market Cap: <= 2.00BPrice: <= $5.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000Rsi 14: <= 30
Ticker
Name
Market Cap$
top bottom
DGNX logo
DGNX
Diginex Ltd
292.33M
SEV logo
SEV
Aptera Motors Corp
90.95M
SURG logo
SURG
Surgepays Inc
25.72M
IOBT logo
IOBT
IO Biotech Inc
14.94M
JL logo
JL
J-Long Group Ltd
13.50M
MTVA logo
MTVA
MetaVia Inc
9.24M
oversold stocks under five dollars
Intellectia · 11 candidates
Price: <= $5.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000Rsi 14: <= 30
Ticker
Name
Market Cap$
top bottom
DGNX logo
DGNX
Diginex Ltd
292.33M
SEV logo
SEV
Aptera Motors Corp
90.95M
SURG logo
SURG
Surgepays Inc
25.72M
IOBT logo
IOBT
IO Biotech Inc
14.94M
JL logo
JL
J-Long Group Ltd
13.50M
MTVA logo
MTVA
MetaVia Inc
9.24M
day trade stocks under $1 today
Intellectia · 15 candidates
Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TRX logo
TRX
TRX Gold Corp
271.29M
BRCC logo
BRCC
BRC Inc
247.13M
RXT logo
RXT
Rackspace Technology Inc
204.93M
HUMA logo
HUMA
Humacyte Inc
189.14M
ATCH logo
ATCH
Atlasclear Holdings Inc
36.30M
COSM logo
COSM
Cosmos Health Inc
19.42M
current bearish stocks using patterns
Intellectia · 18 candidates
Gap Pattern: GapDownMoving Average Relationship: PriceBelowMA5, PriceBelowMA20Candlestick Pattern: DescendingTriangle, HeadAndShoulder, BlackCandlestickSupport Resistance Relationship: PriceFallBelowSupport
Ticker
Name
Market Cap$
top bottom
MRT logo
MRT
Marti Technologies Inc
185.35M
BRLT logo
BRLT
Brilliant Earth Group Inc
162.18M
SUIG logo
SUIG
SUI Group Holdings Ltd
145.37M
WRAP logo
WRAP
Wrap Technologies Inc
127.33M
TORO logo
TORO
Toro Corp
121.18M
ALGS logo
ALGS
Aligos Therapeutics Inc
49.23M

Whales Holding NIVF

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is NewGenIvf Group Ltd (NIVF) stock price today?

The current price of NIVF is 1.21 USD — it has decreased -6.2

What is NewGenIvf Group Ltd (NIVF)'s business?

NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.

What is the price predicton of NIVF Stock?

Wall Street analysts forecast NIVF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NIVF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NewGenIvf Group Ltd (NIVF)'s revenue for the last quarter?

NewGenIvf Group Ltd revenue for the last quarter amounts to 1.43M USD, increased 11.85

What is NewGenIvf Group Ltd (NIVF)'s earnings per share (EPS) for the last quarter?

NewGenIvf Group Ltd. EPS for the last quarter amounts to -7.39 USD, decreased -97.41

How many employees does NewGenIvf Group Ltd (NIVF). have?

NewGenIvf Group Ltd (NIVF) has 87 emplpoyees as of May 10 2026.

What is NewGenIvf Group Ltd (NIVF) market cap?

Today NIVF has the market capitalization of 687.94K USD.